跳至主要内容
临床试验/TCTR20210129003
TCTR20210129003尚未招募1 期

Adjunctive vitamin A and vitamin D3 (Cholecalciferol) for enhancing efficacy of allergen-specific immunotherapy in allergic rhinitis, A randomized, double-blind, placebo-controlled trial

Department of Medicine, Phramongkutklao hospital0 个研究点目标入组 48 人开始时间: 2021年1月29日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 70 Years(—)
性别
All

入选标准

  • 1.Allergic rhinitis with house dust mite sensitization (mono- or polysensitization) with or without asthma
  • 2. No previous treatment with immunotherapy, or quit more than 6 month if the patient used to treatment with immunotherapy
  • 3. Vitamin D level < 30 ng/mL
  • 4. Calcium level < 10.5 mg/dL
  • 5. No pregnant/breastfeeding
  • 6. Accept to intake vitamin A and Vitamin D3

排除标准

  • 1.Patients have contraindication for Vitamin A or Vitamin D3 intake eg, Allergy to vitamin
  • 2. Uncontrolled asthma
  • 3. Abnormal kidney or liver function
  • 4. Underlying cardiac disease, Immunodeficiency
  • 5. On treatment with immunosuppressive drugs/chemotherapy
  • 6. Pregnant or breastfeeding
  • 7. Already intake vitamin A or vitamin D3 before enrollment
  • 8. Vitamin D level > 80 ng/mL
  • 9. Vitamin A level > 60 mcg/mL
  • 10. Calcium level > 10.5 mg/d

研究者

相似试验